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Sensorineural hearing loss is prevalent within society affecting the quality of life of 460
million worldwide. In the majority of cases, this is due to insult or degeneration of
mechanosensory hair cells in the cochlea. In adult mammals, hair cell loss is irreversible
as sensory cells are not replaced spontaneously. Genetic inhibition of Notch signaling
had been shown to induce hair cell formation by transdifferentiation of supporting cells
in young postnatal rodents and provided an impetus for targeting Notch pathway with
small molecule inhibitors for hearing restoration. Here, the oto-regenerative potential of
different γ-secretase inhibitors (GSIs) was evaluated in complementary assay models,
including cell lines, organotypic cultures of the organ of Corti and cochlear organoids
to characterize two novel GSIs (CPD3 and CPD8). GSI-treatment induced hair cell
gene expression in all these models and was effective in increasing hair cell numbers,
in particular outer hair cells, both in baseline conditions and in response to ototoxic
damage. Hair cells were generated from transdifferentiation of supporting cells. Similar
findings were obtained in cochlear organoid cultures, used for the first time to probe
regeneration following sisomicin-induced damage. Finally, effective absorption of a novel
GSI through the round window membrane and hair cell induction was attained in a
whole cochlea culture model and in vivo pharmacokinetic comparisons of transtympanic
delivery of GSIs and different vehicle formulations were successfully conducted in guinea
pigs. This preclinical evaluation of targeting Notch signaling with novel GSIs illustrates
methods of characterization for hearing restoration molecules, enabling translation to
more complex animal studies and clinical research.
Keywords: drug therapy, sensorineural hearing loss, cochlear organoids, hair cell regeneration, Notch signaling,
gamma secretase inhibitor
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INTRODUCTION
Hair cells are the sensory receptors of the vestibular and the
auditory system in the inner ear. In the cochlea there are
two types of auditory hair cells: inner hair cells (IHCs), which
are the primary sound detectors and outer hair cells (OHCs),
which act as acoustic pre-amplifiers (Fettiplace and Hackney,
2006). Hair cells are organized in rows, intercalated by different
types of supporting cells, which exert supporting, trophic and
barrier functions. Degeneration of hair cells is the most common
reason for sensorineural hearing loss and can be caused by
acoustic overstimulation, ototoxic drugs, aging, genetic disorders
or infections (Muller and Barr-Gillespie, 2015; Bommakanti et al.,
2019). Disabling hearing loss affects the quality of life of 5%
of the world population, with high social and economic costs
(Wilson et al., 2017).
Non-mammalian vertebrates regenerate damaged or lost
vestibular as well as auditory hair cells throughout life and
thereby restore sensory functions (Corwin, 1981, 1985; Corwin
and Cotanche, 1988; Ryals and Rubel, 1988; Weisleder and Rubel,
1993). This is mediated by the activity of supporting cells in
the sensory patches, which give rise to new hair cells either
through cell division or transdifferentiation. In mammals, some
degree of spontaneous hair cell regeneration has been reported
for the vestibular organs (Forge et al., 1993; Warchol et al.,
1993; Sayyid et al., 2019; Wang et al., 2019). For the cochlear
auditory epithelium, similar responses have been detected only
in early postnatal stages, prior to hearing onset (Atkinson et al.,
2015). Specifically, spontaneous regeneration has been observed
in mice when hair cells were genetically ablated in a perinatal
window of 4 days (Cox et al., 2014). Fate-mapping showed that
the novel hair cells were generated from supporting cells by
mitotic regeneration and direct transdifferentiation (Bramhall
et al., 2014; Cox et al., 2014; Hu et al., 2016). Despite the limited
extent of spontaneous regeneration, these findings have directed
attention toward chemical and genetic modifications that might
promote and extend the permissive window for regeneration.
The Notch and the Wnt signaling pathways have been recently
targeted to enhance this regenerative potential (Roccio et al.,
2019; Samarajeewa et al., 2019). A subset of supporting cells
within the postnatal cochlear epithelium expresses the Wnt co-
receptor and target Lgr5 (Chai et al., 2011; Chai et al., 2012;
Shi et al., 2012; Zak et al., 2016), a marker of stem cells in
several epithelial organs (Barker et al., 2013). Lgr5+ cells display
enhanced Wnt responsiveness and forced activation of Wnt in
these cells, through genetic modification or chemical stimulation,
causes their proliferation (Jacques et al., 2012; Roccio et al.,
2015; Samarajeewa et al., 2018) as well as their differentiation
into hair cells (Bramhall et al., 2014; Shi et al., 2014; Hu
et al., 2016). LGR5 expression and Wnt responsiveness have also
been confirmed in human fetal cochleas and cochlear organoid
cultures (Roccio et al., 2018).
The Notch signaling pathway controls hair cell and supporting
cell specification and plays a role in tissue regeneration. During
cochlear development, hair cells and supporting cells arise from
a common precursor within the cochlear prosensory domain
(Kelley, 2006; Groves and Fekete, 2012). Notch ligand-receptor
interaction between prosensory progenitors defines the mosaic
organization of hair cells and supporting cells (Kelley, 2006;
Kiernan, 2013). Binding of Notch ligands triggers the cleavage of
the Notch receptor, allowing the translocation of the intracellular
domain to the nucleus, which transcriptionally regulates
developmental gene programs and inner ear cell patterning
(Kopan and Ilagan, 2009; Bray, 2016). Notch activation leads to
the repression of Atoh1, a key transcription factor controlling
hair cell differentiation (Bermingham et al., 1999; Chen et al.,
2002; Woods et al., 2004), and otic progenitor cell fate is directed
to supporting cell lineage in the absence of Atoh1 (Zheng et al.,
2000; Zine et al., 2001; Hayashi et al., 2008; Doetzlhofer et al.,
2009). Chemical or genetic inactivation of Notch signaling can
induce hair cell formation by conversion of supporting cells
(Korrapati et al., 2013; Mizutari et al., 2013; Li et al., 2015; Maass
et al., 2015; Ni et al., 2016b). This has been made evident also
in human prosensory cell-derived organoid cultures as chemical
inhibition of Notch signaling enhanced hair cell differentiation,
supporting the presence of similar mechanisms in human inner
ear specification (Roccio et al., 2018).
Notch receptors are cleaved in the intracellular domain
by enzymes known as γ-secretases (Kopan and Ilagan, 2009;
Andersson and Lendahl, 2014; Bray, 2016). Pharmacological
γ-secretase inhibitors (GSIs) have been tested in postnatal animal
models as a strategy to induce hair cell differentiation and hearing
restoration in vivo (Mizutari et al., 2013; Tona et al., 2014; Maass
et al., 2015). In adult animals deafened by noise overexposure,
inhibition of Notch signaling by local delivery of a single dose
of the GSI LY411575 resulted in new hair cell formation and
small improvements in the cochlear function in the low frequency
regions that were correlated with increased expression of Atoh1
(Mizutari et al., 2013).
The aim of this study was to evaluate and characterize
two novel GSI compounds, hereafter CPD3 and CPD8, and
their efficacy to modify hair cell gene expression and direct de
novo hair cell differentiation. The results reported are based
on a series of in vitro models, including Notch-dependent cell
lines, explants of the organ of Corti (OC), novel whole cochlea
cultures and cochlear organoids derived from the mouse and
rat inner ear. GSIs were also evaluated in models of ototoxic
damage, in order to probe the regenerative potential after
hair cell loss. Finally, we evaluated different GSI-containing
formulations for their permeability through the round window
membrane and performed pharmacokinetic studies to quantify
local concentrations in the perilymph. These preclinical data
supported the advancement of CPD3 to clinical trial. The assays
presented in this study illustrate furthermore a potential pipeline
for ex vivo characterization of hearing restoration molecules.
MATERIALS AND METHODS
Animals
Animal studies (in vivo or ex vivo) were all approved by
either the Animal Care and Experimentation Committee of
the Canton of Bern, Switzerland [license BE 142/16 (SLL);
BE119/12 (MR)] and followed the Swiss national guidelines for
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the performance of animal experiments, or performed under an
approved institutional protocol according to National Institutes
of Health guidelines, or under animal protocols approved by the
Animal Studies Committee of Languedoc Roussillon that comply
with French legislation and European Directives.
Female albino Hartley guinea pigs, 250 g, from Charles River
(France), housed in macrolon cages (2/cage; Innocage Rat Static-
Innovive, Paris) with filter air, were maintained at 22 ± 2◦C
on a 12-h light cycle with standard A04C (UAR) diet and
water “ad libitum.” Lgr5-GFP mice containing an EGFP-IRES-
CreERT2 knock-in allele at the Lgr5 locus were obtained from
the Jackson Labs (Stock 008875, C57BL/6J/RccHsd background).
Atoh1-nGFP transgenic mice (C57Bl/6J background) were from
Jane Johnson (Lumpkin et al., 2003). Wistar rats were obtained
from Charles River.
Pharmacokinetics in the Inner Ear
γ-secretase inhibitors pharmacokinetic studies tested CPD3,
CPD8 (Eli Lilly) or LY411575 (Stemcell Technologies) each
formulated at 3.4 mg/ml in the following vehicles, 10%
Poloxamer 338 (Sigma), 20% Poloxamer 338, 70% PEG400
(Sigma) or 1% hyaluronic acid (HA-700; Lifecore, Chaska, MN,
United States) all prepared with PBS (pH 6.2). A single 70 µl
injection of the formulated compound (total dose, 870 µg/kg)
was delivered to the middle ear space of isoflurane-anesthetized
guinea pigs by transtympanic administration. Perilymph from
treated animals (perilymph volumes, >2 µl) was collected at
time points up to 48 h post-administration (CILcare, Montpellier,
France). Briefly, concentrations of each compound in perilymph
and plasma, as well as controls prepared in artificial perilymph,
were measured by LC-MS/MS on an AB Sciex, API 4000 mass
spectrometer using an Onyx C18 5 µm 50∗2.0 mm separation
column (Oroxcell, Romainville, France).
Cell Lines and Tissue Culture
The human colon cancer cell line LS174T (CL-188; ATCC)
was cultured without antibiotics in 1% FBS/Eagle’s Minimum
Essential Medium (MEM; Thermo Fisher) (Asakura et al.,
2018). The cells were exposed to GSIs or vehicle for 4 days,
prior to analysis.
Otic Sphere Assay
The generation of otic spheres followed previously described
protocols (Oshima et al., 2009) with modifications during
differentiation phase to test GSIs. Briefly, OCs were dissociated
and single cells were deposited in ultralow-cluster plates
(Corning) and expanded in “full otic medium” consisting of
DMEM/F12, supplemented with N2, B27 (Thermo Fisher),
EGF (20 ng/ml; Chemicon), bFGF (10 ng/ml; Chemicon),
IGF-1 (50 ng/ml; Chemicon), and heparan sulfate (50 ng/ml;
Sigma-Aldrich). After culturing for 3–4 days at 37◦C, spheres
were collected, plated in cell culture-treated 96 well-plate
and cultured in DMEM/F12, supplemented with N2, B27
with/without GSIs for 7 days after which they were lysed
for RNA extraction.
Dissection and Isolation of Organ of
Corti for Sensory Epithelium Explant
Culture
OC explants were isolated from postnatal day 2 (P2) Wistar
rats, P0-P2 mice (Lgr5-GFP or Atoh1-nGFP mice). Dissection of
the cochlea under a stereomicroscope (Nikon SMZ800, Japan)
allowed OC separation from stria vascularis and modiolus,
and the sensory epithelium was plated with hair cells facing
up on Cell-Tak (Corning, United States)-coated transwell-clear
inserts (6-well format, 0.4 µm pore, Corning, United States).
Dissection medium was exchanged for 1.5 ml full otic medium
supplemented with 10% FBS (Invitrogen) and 0.01% Ampicillin
(Sigma), added under the insert membrane, maintaining the OC
under a thin film of medium during culture at 37◦C. 5-ethyl-2′-
deoxyuridine (EdU, 5 µM, Life Technologies) was added directly
in the medium when indicated.
GSI-Treatment of Organotypic Cultures
Concentrations of small molecule GSIs {LY411575, CPD3,
CPD8, DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester; Sigma)} were prepared in DMSO and
are indicated in Figure Legends and Results. DMSO included as
Control. Treatment groups were assigned randomly.
Ototoxic Insults in Organotypic Cultures
To induce ototoxic damage, medium was removed from the OC
cultures on the day after dissection and either 200 µM sisomicin
(Sigma) in full otic medium, or 108 cfu/ml Streptococcus
pneumoniae (described below) in ampicillin-free and FBS-free
otic medium were added under the transwell membrane (lower
compartment) of the cultivation system. After 2 h of exposure to
the ototoxic insult, OCs were carefully washed 3 times and culture
was continued for 4 days in fresh full otic medium.
Streptococcus pneumoniae Inoculum
A clinical isolate of S. pneumoniae, serotype 3 was used as
previously described (Leib et al., 2000; Perny et al., 2017). Briefly,
bacteria were cultured overnight (ON) in brain-heart infusion
medium and diluted 1:10 in fresh medium the following day.
Bacteria were grown until the logarithmic phase was reached
(after approximately 5 h). The culture was centrifuged for
10 min at 3,100 g at 4◦C and the pellet was resuspended in
0.85% NaCl and centrifuged again. Bacteria were diluted to
the desired optical density (OD570 nm) and the final inoculum
concentration was determined by plating serial dilutions on
Columbia sheep blood agar.
Ex vivo Whole Cochlea Culture
To culture the intact cochlea of P0–P1 mice, the entire otic
capsule (cochlea and semicircular canals) was carefully dissected.
Connective tissues and nerves were removed to clear the round
window niche and the capsule was positioned with the round
window facing up in a sterile 35 mm dish. A surgical sponge
was employed to blot dry the interior of the round window
niche, which was then filled with 2 µl of the formulated drug
and applied with a small pipette tip. Following 2 h of drug
treatment at 37◦C with 5% CO2, the tissue was transferred to a
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50 ml conical tube containing 10 ml medium (DMEM, 5%FBS,
5% horse serum and ampicillin) and the tube was sparged with
95% O2/5% CO2 for 5–10 min and incubated for 2 days at 37◦C,
rotating on a roller/rocker (SCILOGEX MX-T6-S Analog Tube
Roller) at 15–17 rpm.
Dissection and Isolation of Organ of
Corti Cells for Organoid Culture
On day 0, the cochlear sensory epithelium was dissected and
the OC was separated from the modiolus and stria vascularis, as
described above, from either Wistar rat pups (P2), Lgr5-GFP mice
(P0–P2) or Atoh1-GFP mice (P0–P2). To separate the sensory
epithelial layer from underlying mesenchyme and neurons, the
OC was placed in a 100 µl drop of Matrisperse Cell Recovery
Solution (Corning) for 1 h at RT, then delaminated with the
aid of forceps. Gentle enzymatic dissociation of hair cells and
supporting cells followed with 100 µl drop of TrypLE (Gibco),
20 min at 37◦C, then mechanical trituration in DMEM/F12.
The cell suspension was centrifuged for 5 min at 500 g at 4◦C
and resuspended in DMEM/F12 medium supplemented with
B27 and N2 (Invitrogen), EGF (50 ng/ml), bFGF (50 ng/ml),
IGF (25 ng/ml), CHIR99021 (GSK-3β inhibitor, 3 µM, Merck),
valproic acid (HDAC inhibitor, 1 mM, Sigma), 2-phospho-
L-ascorbic acid (280 µM, Stemcell Technologies) and 0.01%
ampicillin (Sigma). Cells were plated at 2,000 cells per well on
96 wells plate (Corning Costar; ultra-low attachment, round-
bottom) to allow aggregation at 37◦C. On day 1, Matrigel (GF-
depleted, Corning; 2% stock) was added to a final concentration
of 0.18 mg/ml. On day 3, cells were transferred to 24 wells plate
(ultra-low attachment; Corning Costar), pooling the organoid
aggregates from 4 to 5 wells (96 well-plate) to one 24-well,
culturing at 37◦C and exchanging half medium and Matrigel
every other day, On day 10, organoids were differentiated by
replacing medium with DMEM/F12 supplemented with B27,
N2, CHIR99021 (3 µM), and Notch inhibitors CPD3 (5 µM)
or LY411575 (5 µM), and culture was continued as above for
another 10 days.
Organoid Ototoxic Treatment
On day 20, differentiated organoids were exposed to sisomicin
for 2 h at the concentration of 500 µM. The medium was then
washed and replaced with differentiation medium with/without
GSI for an additional 4 or 7 days. For propidium iodide (PI)
uptake, on day 24 of in vitro differentiation, cells were incubated
in the presence of PI (5 µg/ml) for 5 min and subsequently
washed and fixed. Immunostaining was then performed as
indicated below.
Gene Expression by RT-PCR
Cells or tissue were lysed using RLT Lysis Buffer (Qiagen) and
high purity RNA was prepared on the MagNA Pure instrument
using MagNA Pure 96 Cellular RNA LV Kit (Roche). Reagents
from Thermo Fisher were used for cDNA synthesis by reverse
transcription using random hexamers. Resulting cDNA was
RNAse H treated and amplified by TaqMan GEX mastermix and
PCR primers and probes for human ATOH1 (Hs00944192_s1)
and TBP (Hs00427620_m1), mouse Tbp (Mm00446971_m1),
Atoh1 (Mm00476035_s1), Hes5 (Mm00439311_g1), Pouf4s
(Mm04213795_s1), and Myo7a (Mm01274015_m1) on the
Applied Biosystems QuantStudio 7 Flex Real-Time PCR System.
Normalized to Tbp, relative gene expression fold-change was
quantified and compared between experimental and control
conditions by11Ct calculation.
Immunohistochemistry and Imaging of
Organ of Corti Explants
Following culture, explants were washed (PBS) and fixed for
10 min at room temperature (RT) with 4% paraformaldehyde
(PFA). Samples were permeabilized with 3% Triton X-100 for
30 min at RT and blocked with blocking buffer containing
2% bovine serum albumin (BSA) and 0.01% Triton X-
100 for 1 h at RT.
Dividing cells were labeled with, 5-ethyl-2′-deoxyuridine
(EdU) and detected with Click-it Plus kit (Life Technologies).
Primary antibodies [mouse anti-Pou4f3 (1:200; Santa Cruz
Biotechnology, United States) and rabbit anti-Sox2 (1:200; Cell
Signalling Tech, United States)] were incubated in blocking
buffer ON at 4◦C. Samples were washed and incubated for
2 h at RT with secondary antibodies [goat anti-mouse Alexa
Fluor 488 and goat anti-rabbit Alexa Fluor 555 (1:500 dilution,
Invitrogen, United States)], as well as Phalloidin-Alexa Fluor 647
(Sigma). Explants were washed and mounted on glass slides with
Fluoroshield containing DAPI (Sigma).
Explants were visualized with a Nikon Eclipse Ti-E for
overview purposes. Individual z-planes at an interval of 5 µm
were acquired with a confocal laser-scanning microscope (Zeiss
LSM710, Plan-Apochromat 20×/0.8 NA objective) to ensure
visualization of all hair cells.
Image processing was performed with the open-source image
processing software FIJI, version 2.0 (Schindelin et al., 2012).
Hair cells were quantified by counting Pou4f3 or Myo7a positive
cells of the organ of Corti at three random microscopic fields for
each cochlear region (base, middle, and apex) covering in total
at least 1,200 µm. The number of hair cells (IHCs and OHCs) is
expressed as unit per 100 µm.
Immunofluorescent Staining and
Imaging of Cochlear Organoids
For staining and imaging, organoids were allowed to adhere
ON onto transwell-permeable support membranes (Corning) in
12-well plates coated with 100% Matrigel. The next day, they
were fixed with 4% PFA (10 min). Cells were permeabilized with
3% Triton-X 100 for 10 min and incubated ON with blocking
buffer containing 2% BSA and 0.01% Triton-X 100. Primary
antibodies were incubated ON at 4◦C (1:200 dilution). Anti-
Sox2 (mouse, BD Bioscience), anti-Pou4f3/Brn-3c (mouse, Santa
Cruz Biotechnology) anti-Myo7a (rabbit, Enzo Life Sciences)
and anti-p27/Kip1 (rabbit, Abcam). Organoids were then rinsed
and incubated ON with the secondary antibodies as described
above. For FM1-43 uptake, organoids were first incubated with
Hoechst (10 µg/ml), 30 min at 37◦C, then a brief incubation
FM1-43 (5 µM; Life Technologies) for 30 s, and washed twice
before fixation (4% PFA). To image organoids, inserts were placed
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face down in a 24 well glass bottom plate (MatTek) and imaged
on a Zeiss LSM710 laser scanning microscope (5 µm Z-stacks
intervals). Compiled Z-projections were processed (FIJI, ver2.0)
and hair cells quantified on individual planes with manual cell
counter plugin, by evaluation of cytosolic expression and nuclear
exclusion of Myo7a. Organoid volumes were estimated from the
sum of the product of the area of the organoid (at each plane) and
the Z stack height.
Immunofluorescent Staining of Inner Ear
Whole Mounts
For whole-mount immunohistochemistry, whole cochleae were
fixed (4% PFA) ON at 4◦C, then incubated in primary
antibodies (72 h, rocking at 4◦C), goat anti-GFP polyclonal Ab
(AbCam, ab6673) and rabbit anti-Sox2 polyclonal IgG (GenTex,
GTX101506) in 4% normal donkey serum. Following extended
washes (over 24 h), cochlea were incubated for 24 h in secondary
antibodies donkey anti-goat Alexa 488 (Thermo Fisher, A11055)
and donkey anti-rabbit Alexa 647 (Thermo Fisher, A31573) and
extensively washed. The intact OC were then microdissected
from cochleae and mounted on a coverslip for confocal imaging.
A LSM 510 Confocal Microscope (Zeiss) utilizing 63X Zeiss Plan-
APOCHROMAT DIC oil, 1.4NA and Zen 2009 LSM imaging
software was used to optically scan mid-apex regions of OCs.
Cellular quantification and image analysis computation were
performed with Imaris 8.2.1 software (Bitplane).
Data Analysis and Statistics
Statistical analysis was performed with GraphPad Prism software
(Prism9; GraphPad Software Inc., San Diego, CA, United States).
For explant cultures, when the number of explants/replicates was
not sufficient to test for Gaussian distribution normal distribution
of the data was assumed based on previous experiments (Perny
et al., 2017; Erni et al., 2019). Alternatively, the distribution of
the datasets was tested by D’Agostino and Pearson normality
test. Unpaired t-tests were used to compare parametric data sets
of two groups. Welch’s correction was applied if variances were
not equal. For non-parametric data, the Mann–Whitney test was
adopted. One-way ANOVA was used to determine the difference
in means among multiple groups and multiple comparison
correction was tested. Graphs indicate the single data point, the
mean values± standard deviation. IC50s were calculated by non-
linear regression of data normalized by percent change from
controls to compare multiple experiments. Differences in IC50s
from Best fit data were compared by Least Squares (F-test; Extra
sum of squares; alpha = 0.05). The number of technical and
biological replicates are indicated in Figure Legends.
RESULTS
Activity and Inner Ear Pharmacokinetics
of GSIs Examined in This Study
To measure the relative potency between different GSIs, a
pharmacological assay was initially used to identify the dose
ranges effective to induce ATOH1 expression. The cell line
LS174T, a human colorectal adenocarcinoma, was used to
evaluate Notch-dependent expression of ATOH1 (Kazanjian
et al., 2010). Two compounds from Eli Lilly, designated
LY3056480 (CPD3) and LY3056359 (CPD8) (Figures 1A,B) were
compared with the commercially available GSIs LY411575 and
DAPT. ATOH1 expression was upregulated by GSI treatment in
a dose-dependent manner after 72 h. IC50s for the 4 GSIs were
17.3 nM (CPD3; open circles), 62.0 nM (CPD8; filled diamonds),
0.4 nM (LY411575; open triangles) and 1.4 µM (DAPT; open
squares). These IC50s ranked the potency for CPD3 and CPD8
intermediate between that of LY411575 and DAPT, with the
CPD3 IC50 measured as significantly lower than that of CPD8
(Figure 1C; p < 0.05). The intermediate potency of CPD3 and 8
was likely to be adequate to achieve levels above the IC50 after
dilution into perilymph in the inner ear.
To verify this, in vivo compound concentrations were
measured in perilymph of guinea pigs after intratympanic
delivery of GSIs into the middle ear. Initially, four vehicle
formulations, with different physical properties, were tested,
poloxamer 338 (POX; at 10% or 20%), hyaluronic acid (HA),
or polyethylene glycol 400 (PEG). For this comparison only
one GSI was prepared in each formulation (CPD3, 3.4 mg/ml)
and a single dose was injected into the middle ear. Perilymph
and plasma were sampled for 48 h (Figure 1D). The highest
perilymph concentrations were achieved in 10% POX and 20%
POX formulations, respectively. The mean, maximal perilymph
concentration for these formulations was reached at 0.5 h post-
dosing and declined over time. Detectable CPD3 remained in
perilymph throughout the test, and at 48 h concentrations
between 485 ng/ml (1.0 µM) and 1,000 ng/ml (2.1 µM)
indicated sufficient residence times and concentrations for GSI
activity. Next, using only 10% POX as vehicle, inner ear
adsorption was compared between CPD3, CPD8, and LY411575
by transtympanic injections (Figure 1D, inset). Perilymph
concentrations were sampled at 0.5, 1, and 6 h post-dosing, with
concentrations of CPD3, CPD8, and LY411575 quantifiable at
all time points. Each compound achieved levels several folds
above their respective IC50s. The mean maximal perilymph
concentration of CPD3 at 0.5 h post-dosing was 85,489 ng/ml
(183 µM), then declined at 1 h to 12,928 ng/ml (27.7 µM), and at
6 h to 12,652 ng/ml (27.1 µM). GSIs in plasma samples were not
detected (data not shown).
GSI-Mediated Induction of Hair Cell
Gene Expression and de novo
Generation of Hair Cells in the Neonatal
Cochlear Sensory Epithelium
CPD3 and CPD8 were further compared for their potency
to induce hair cell gene expression in otic sphere assays
(Oshima et al., 2009). Cells were first expanded in presence of
growth factors, and in a second step differentiated by growth
factor removal and GSI treatment. Both CPD3 and CPD8
significantly induced Atoh1, Pou4f3, and Myo7a expression in
dose-responsive manner (p< 0.05; two-way ANOVA). However,
CPD3 (IC50 = 6.7 nM) was more potent in Atoh1 upregulation
than CPD8 (IC50 = 302.8 nM; p < 0.05; two-way ANOVA). This
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FIGURE 1 | γ-secretase inhibitors (GSI) characterization. (A) Structures of the two novel GSIs tested in these studies. (B) Properties of the two GSIs (CPD3 and
CPD8). Molecular weights (MW), logarithms of the octanol-water partition coefficients (logP), and polar surface areas (PSA). (C) Dose-response curves for CPD3,
CPD8, DAPT, and LY411575 in the human intestinal epithelial cell line LS174T. Fold-change of human ATOH1 expression in response to GSI treatment after 72 h.
IC50s for the 4 GSIs were 17.3 nM (CPD3; open circles), 62.0 nM (CPD8; filled diamonds), 0.4 nM (LY411575; open triangles), and 1.4 µM (DAPT; open squares).
Atoh1 expression is reported as fold-change relative to carrier control [0.05% dimethyl sulfoxide (DMSO)]. Duplicate measurements are from 4 separate experiments
(total n = 8). (D) Inner ear pharmacokinetic study in albino Hartley guinea pigs. A single transtympanic dose of CPD3 in [20% poloxamer (POX; open triangle), 10%
POX; closed square], hyaluronic acid (HA; open square), or PEG 400 (closed circle) resulted in detectable CPD3 concentrations in the perilymph up to 48 h
post-dosing. A single transtympanic dose of CPD3 (squares), CPD8 (triangles), and LY411575 (circles) in 10% POX resulted in perilymph levels shown at 0.5, 1, and
6 h post-dosing (inset graph).
indicated a modest advantage of CPD3 in eliciting expression
of the early hair cell marker Atoh1, but similar potency on
expression of some later markers of HC differentiation, Pou4f3
and Myo7a (Figure 2A). From the results of two screening assays,
CPD3 was selected for additional characterization studies based
on its lower IC50 to induce Atoh1/ATOH1 expression in the otic
spheres and LS174T cells, respectively.
Subsequently, the analysis of gene expression changes induced
by CPD3 was assessed in OC explants. As control GSIs,
LY411575 and DAPT were used. CPD3 (1 µM) increased the
expression levels of several hair cell genes: Atoh1 (3.7 ± 0.54-
fold; p < 0.005), Pou4f3 (2.04 ± 0.35-fold; p < 0.05) and
Myo7a (1.73 ± 0.33-fold; ns, one-way ANOVA with multiple
comparison). Similar inductions were observed for LY411575
(5 µM): Atoh1 (4.34± 0.82-fold; p< 0.001), Pou4f3 (1.46± 0.26-
fold, ns), and Myo7a (1.42 ± 0.31-fold; ns, one-way ANOVA
with multiple comparison), as well as for DAPT (5 µM): Atoh1
(2.36 ± 0.39-fold, ns) Myo7a (1.59 ± 0.21-fold, ns), and Pou4f3
(2.14± 0.36-fold, ns) (Figure 2B).
In order to evaluate the potency of the compounds to induce
de novo hair cell formation, OC explant cultures of the early
postnatal organs were exposed to GSIs and hair cell numbers
were quantified in cultures of mouse (Figure 2C) and rat tissue
(Figures 2D,E). In both species, the GSIs increased OHC counts,
whereas IHC counts remained unchanged. Here, OHC induction
by CPD3 was moreover limited to the apical region (p < 0.05,
unpaired t-test; Figure 2E).
To assess the regenerative potential of CPD3 in response to
hair cell damage, treatment with CPD3 was tested in rat OC
explants in two ototoxicity models: aminoglycoside exposure,
specifically using sisomicin (Huth et al., 2015), and exposure to
living S. pneumoniae (Perny et al., 2017; Erni et al., 2019). As
reported previously, sisomicin caused a dramatic loss of hair cells,
in particular OHCs, in the basal cochlear domain (Figure 3A)
(Perny et al., 2017; Erni et al., 2019). Hair cell numbers in the apex
remained comparable to control explants (dashed line/yellow
shaded area), and increased OHC numbers elicited from CPD3
were not statistically significant, possibly due to this blunted
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FIGURE 2 | GSI-mediated induction of hair cell gene expression and de novo generation of hair cells in the neonatal cochlear sensory epithelium. (A) Gene
expression changes of Atoh1, Pou4f3, and Myo7a in response to Notch pathway inhibition by CPD3 (solid lines, triangles) and CPD8 (dashed lines, open square) in
otic spheres. Gene expression is reported as fold-change relative to carrier control-treated (DMSO, 0.05%). (n = 9–12). EC50 values are significantly different for
Atoh1 (p < 0.05, F-Test). (B) Gene expression analysis for the hair cell genes Atoh-1, Myo7a, and Pou4f3. DMSO control n = 13, CPD3 n = 12, LY411575 n = 9,
DAPT n = 6 from 2–4 independent experiments. OC explants were cultured for 4 days with/without GSI prior to lysis and analysis. One-way ANOVA with
(Continued)
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FIGURE 2 | Continued
Dunnett’s multiple comparison test, each condition compared to DMSO control. (*p < 0.05, **p < 0.005, ***p < 0.001). (C) Cell counts of Atoh1 positive HCs (OHC
left, IHC right) in the mouse cochlear sensory epithelium in the mid-apex region after 7 days in culture with different γ-secretase inhibitors. One-way ANOVA
Dunnett’s multiple comparison test, each condition compared to DMSO control. (*p < 0.05; n = 3–5 independent experiments). (D) Quantification of Pou4f3 positive
HCs (OHC left, IHC right) in the cochlear sensory epithelium from P2 rats in the apical domain after 8 days in culture with different γ-secretase inhibitors. One-way
ANOVA with Dunnett’s multiple comparison test, each condition compared to DMSO control (*p < 0.05, n = 3). Representative immunohistological images of the
apical domain after 8 days incubation (inset). scale bar = 20 µm. (E) Quantification of Pou4f3 positive OHCs in the apex, middle and basal domain of organ of Corti
explants from rats after 4 days of CPD3 treatment compared to DMSO (*p < 0.05, unpaired t-test) n = 4–6 explants from 2 independent experiments.
baseline of damage (Figure 3B). Interestingly, an increase in
Pou4f3+/Sox2+ double-positive cells at the apical side of the
organ of Corti was detected, where 3rd Deiters’ and Hensen’s
cells are located (Figure 3C). These double positive cells lacked
hair bundles (F-actin) (Figure 3C, arrows), suggesting they
were newly generated. Pou4f3/Sox2 double-positive cells were
observed only in the apical domain of explants treated with CPD3
(Figure 3D) (p = 0.057, Unpaired t-test with Welch’s correction).
For bacteria-induced ototoxicity, the damage was moderate
in these experiments (Figures 3E,F). Explants that were
subsequently treated with CPD3 for 4 days showed more OHCs
in all turns of the organ of Corti, compared to DMSO-treated
organs, with a density similar to that of undamaged explants
(Figure 3F). Again, some cells co-expressed Pou4f3 and Sox2,
possibly indicating a process of direct transdifferentiation. This
was supported by the lack of EdU incorporation (Figures 3E–
G). Quantification of Pou4f3/Sox2 double-positive cells showed
increased occurrence when explants were treated with CPD3 after
damage, however, only in the apical domain. These effects did not
reach statistical significance (Figure 3H).
Hair Cell Formation in Whole Cochlea
Culture
To assess the permeability of the compounds across the round
window membrane, a novel ex vivo model was devised to
compare drug entry, after delivery to the exterior of the cochlear
capsule, to resemble middle ear application. Specifically, CPD3
application was tested in organotypic culture of the entire
otic capsule (Figure 4). CPD3, formulated at two different
concentrations (1 and 7.2 mM) in 70% PEG400 or 10%
POX338 (POX), was applied at the round window niche. Drug
formulations were allowed to absorb briefly into the cochlea prior
to the 48 h culture. Confocal microscope images of stained cells
in four landmark regions (Base, Mid-Base, Mid-Apex, and Apex)
revealed a dose-dependent increase in hair cell number (Atoh1-
GFP positive cells) upon GSI treatment (Figures 4A–D). The
total number of Atoh1+ hair cells, independent of the anatomical
location, showed robust increases over control vehicles in both
formulations. In the PEG400 formulation, CPD3 stimulated a
60.1% increase in Atoh1+ hair cells at 7.2 mM (87 ± 15 hair
cells/100 µm) above vehicle-only (54 ± 5 hair cells/100 µm;
p < 0.001, One-way ANOVA with Multiple comparison), but
no change at the lower dose (1 mM; 54 ± 7 hair cells/100 µm).
In the POX338 formulation, CPD3 stimulated Atoh1+ hair cell
significant increases both in the low dose (23.3%) and at the
high dose (Figure 4D, green dots; 54.4%; from 59 ± 6 hair
cells/100 µm in vehicle-only, 72 ± 11 hair cells/100 µm at
1 mM and 90 ± 20 hair cells/100 µm at 7.2 mM; *p < 0.05;
***p < 0.001, one-way ANOVA with multiple comparison). For
the POX338 formulation, we further characterized the number of
Sox2+ supporting cells in the sensory epithelium. A significant
decrease in supporting cell (Sox2+) counts was concomitant
to the increase in Atoh1+ hair cells (Figures 4C,D, red dots;
***p < 0.001, one-way ANOVA with multiple comparison),
in agreement with a previously reported transdifferentiation
mechanism (Bramhall et al., 2014). Also in this model, we
observed a trend for new hair cells to be greater toward the
apex than the base in agreement with the results obtained with
the OC organotypic culture and indicated GSI exposure was
throughout the entire length of the organ of Corti length during
the culture period.
CDP3-Induced Hair Cell Differentiation in
Cochlear Organoids
CPD3 was then tested in cochlear organoid culture (McLean
et al., 2017; Lenz et al., 2019). In this model, supporting
cells/progenitors are first expanded and subsequently
differentiated to hair cells by growth factors withdrawal and
addition of CHIR99021, to activate Wnt signaling, and inhibition
of Notch, by GSI. Previously, LY411575 was used in similar
experiments (McLean et al., 2017; Lenz et al., 2019). The use of
Lgr5-GFP reporter mice enabled verification of Lgr5 induction
during expansion (Figure 5A). Within 10 days of differentiation,
cells of hair cell phenotypes were observed (Figure 5B), which
also displayed uptake of the styryl dye FM1-43, an indirect
readout for functional hair cells (Figures 5C,D).
Evaluating CPD3 efficacy to induce hair cell formation during
the differentiation phase was assessed by gene expression changes
of hair cell and supporting cell specific genes by RT-PCR.
For this specific set of experiments, Atoh1-nGFP mice were
used to facilitate the verification of hair cell induction prior to
cell lysis for RNA isolation (data not shown). While hair cell
genes (Atoh1; Pou4f3; and Myo7a) were upregulated, supporting
cell genes (Hes5 and Lgr5) were as expected downregulated.
Sox2 mRNA expression was, however, not changed in this
time-frame (Supplementary Figure 1). CPD3 (5 µM) induced
Atoh1 expression (8.07 ± 5.6-fold; p < 0.0001, unpaired t-test),
Pou4f3 expression (12.65 ± 11.07-fold; p < 0.0005, unpaired
t-test) and Myo7a (9.9 ± 10.5-fold; p < 0.005, unpaired
t-test) compared to untreated samples. Hes5 expression was
downregulated fourfold (0.24% ± 0.4; p < 0.05 unpaired t-test)
(Figure 5E). When compared to LY411575, comparable effects
were observed for hair cells and supporting cell gene markers
(Supplementary Figure 1).
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FIGURE 3 | GSI treatment after ototoxic damage. (A) Representative immunohistological pictures of the base (B), midbase (MB), midapex (MA), and apex (A) of a
sisomicin treated explant stained for hair cells (Myo7a), hair bundles (F-actin). Scale bars: 10 µm. (B) Quantification of OHCs in sisomicin-treated explants (2 h;
200 µM), 4 days after ototoxic insult, and cultured in presence or absence of CPD3. Dashed line shows the mean of the undamaged control explants with SD in
yellow (n = 3–4 explants). (C) Immunohistological images of an apical OC turn after ototoxic damage with sisomicin and subsequent treatment with CPD3. Some
cells co-expressed hair cell marker Pou4f3 and supporting cell marker Sox2 but did not show F-actin positive hair bundles (arrows). Scale bars = 10 µm. Boxed
area is enlarged in the panels on the right showing merged and single channels. (D) Quantification of Pou4f3/Sox2 double-positive cells in the apex of
sisomicin-exposed explants, treated with CPD3 or DMSO (ns, n = 3–4 explants). (E) Representative immunohistological images of the apical turn of the organ of
Corti 4 days after exposure to S. pneumoniae and treatment with CPD3. Scale bar = 50 µm. (F) OHC quantification after bacteria-induced damage. Dashed line
shows the mean of the undamaged control explants with SD in yellow. (n = 3,4 explants per condition). (p < 0.05, unpaired t-test, between CPD3 ± and each
location). (G) Immunostaining of the organ of Corti apical domain for Pou4f3 and Sox2. Double-positive cells are highlighted with circles. EdU (white). Scale
bar = 10 µm. (H) Quantification of Pou4f3/Sox2 double-positive cells in the apex after exposure to S. pneumoniae. (n = 3–4 explants per condition. ns, unpaired
t-test with Welch’s correction). *p < 0.05.
Cochlear organoids derived from the rat sensory epithelium
allowed corroboration of CPD3 to induce hair cell formation in
another species model (Figures 5F–J and Supplementary
Figure 2). As above, successful proliferation of Sox2+
progenitors (Supplementary Figure 2) was followed by cellular
differentiation to generate Myo7a+ hair cells (Figures 5F–H).
Hair cells demonstrated the ability to incorporate FM1-43,
suggesting their functional differentiation in rat organoids also
(Figure 5H). Interestingly, a subset of organoids contained cells
double positive for Myo7a and Sox2, suggesting intermediate
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 August 2021 | Volume 9 | Article 710159
fcell-09-710159 August 9, 2021 Time: 12:40 # 10
Erni et al. GSI-Induced Cochlear Hair Cell Differentiation
FIGURE 4 | Hair cell quantification in whole cochlea culture. (A) Hair cell counts from whole cochea culture with directly applied CPD3 in 70% PEG400 (1 mM or
7.2 mM). Atoh1-GFP positive hair cells in different organ of Corti regions (B, base; MB, mid-base; MA, mid-apex; A, apex) (n = 3 independent experiments). (B) Hair
cell counts from whole cochea culture with directly applied CPD3 in 10% POX338 (1 mM;, or 7.2 mM). Atoh1-GFP positive hair cells in different organ of Corti
regions (B, base; MB, mid-base; MA, mid-apex; A, apex; n = 3 independent experiments). (C) Immunostained inner ear sensory epithelia following whole cochlea
culture with direct application of CPD3 (1 and 7.2 mM; Vehicle, 10% POX338). 3D projections of confocal stacks at mid-base region of organ of Corti, Atoh1-GFP
(hair cells, green) and Sox2 (supporting cells, red). (D) Quantification of Atoh1-GFP-positive (green dots) and Sox2-positive cells (red dots) after direct application of
CPD3 (1 or 7.2 mM), or vehicle formulated in 10% POX338. (*p < 0.05; ***p < 0.001, one-way ANOVA with multiple comparison; n = 12; 3 independent
experiments; all regions-base to apex).
phenotypes during the transdifferentiation from supporting cells
or immaturity (Figure 5G). The addition of CPD3 significantly
increased hair cell numbers during differentiation (p < 0.05
Welch’s test) (Figure 5I), and CPD3 was then compared to
LY411575 in the differentiation phase. For both compounds,
higher numbers of hair cells per organoid could be differentiated
relative to vehicle-treated samples, however, this did not reach
statistical significance (Figure 5J). Some hair cells could also be
identified when no GSI was added to the differentiation medium
(DMSO group), with numbers comparable to what was obtained
at the end of the expansion phase. To adjust for variation in size
of the organoids, hair cell counts are expressed as relative to the
organoid volume.
Cochlear Organoids Hair Cells Are
Sensitive to Sisomicin-Induced Damage
Finally, the regenerative potential of CPD3 was assessed
with rat cochlear organoids testing the efficacy of CPD3 to
transdifferentiate any remaining supporting cells after ototoxic
damage. Sisomicin (500 µM) was applied for 2 h at day 20 of
differentiation, followed by 4–7 days culture in absence or in
presence of GSIs. Qualitative assessment of the ototoxic effect
of the aminoglycoside showed features of damage, including
abnormal morphologies, cell shrinkage and uptake of propidium
iodide in Myo7a positive cells, consistent with sisomicin-induced
cell death (Figures 6A–C). A decrease in Myo7a+ hair cells was
detected 7 days following sisomicin damage (Figure 6D). From
the baseline of sisomicin-treated hair cell numbers, a significant
increase in Myo7a+ hair cells was restored in organoids that
were cultured in presence of CPD3 (p < 0.001, unpaired t-test
with Welch’s correction) (Figure 6D). While the total number of
Sox2 positive cells in the organoid did not change in response
to CPD3 (Figure 6E), the number of Myo7a+/Sox2+ hair cells
did increase (p < 0.001, unpaired t-test with Welch’s correction)
(Figure 6F). Together these data indicated that, GSI treatment
did induce de novo hair cell formation from supporting cells in
the sisomicin-damage organoid model.
DISCUSSION
Reactivation of signaling pathways that contribute to hair cell
development during embryonic and fetal stages is one of the
approaches under investigation to trigger tissue regeneration of
the inner ear sensory epithelia. This strategy targets supporting
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FIGURE 5 | Assessment of GSI effects in cochlear organoid culture. (A) Representative example of Lgr5-GFP organoids after 10 days expansion (exp D10). Scale
bar = 50 µm. (B) Immunostaining Lgr5-GFP organoids at 20 days of differentiation (diff D20) for Myo7a (white) and F-Actin (Phalloidin, green). Scale bar = 50 µm.
(C,D) Incorporation of FM1-43-FX in organoid exposed to the dye for 30 s, subsequently fixed and immunostained for Myo7a (white) and F-Actin (green). Scale
bar = 50 µm. (E) Gene expression analysis by RT-PCR of hair cell genes (Atoh1, Pou4f3, and Myo7a) and supporting cell gene (Hes5) in organoids derived from
Atoh1-GFP mice at the end of differentiation. Ctrl (DMSO) and CPD3 (5 µM; *p < 0.05, **p < 0.005, ***P < 0.0005, ****p < 0.0001; Unpaired t-test; n = 14).
(F) Representative example of organoids derived from the P2 rats cochlear sensory epithelium immunostained for the hair cell markers Myo7a (red) and F-Actin
(Phalloidin, white) at day 10 of expansion (exp D10) and after day 10 of differentiation (diff D20). Scale bar = 25 µm. (G) Representative immunostaining at day 20 of
differentiation for Myo7a, Sox2, and F-Actin. single Z stack. Scale bar = 50 µm. (H) FM1-43 uptake (yellow) at day 20 of differentiation. Scale bar = 10 µm.
(I) Quantification of hair cell numbers in vitro (normalized for the volume of the organoids in mm3 (×10−5) at 10 days of expansion (exp D10) or at 20 days of
(Continued)
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FIGURE 5 | Continued
differentiation in the presence of CPD3 (diff D20) n = 18 per group (p < 0.05; unpaired t-test with Welch’s correction). (J) Relative hair cells at the end of
differentiation (normalized for organoid size). Total hair cells per organoid prior to normalization: DMSO (9.4 ± 11.2; n = 7), CPD3 (22.8 ± 18.0; n = 24), and
LY411575 (17.17 ± 20.9; n = 15).
cells, given the common developmental origin, and aims to force
their de novo differentiation to hair cells (Roccio et al., 2019).
With this rationale, Notch signaling was manipulated in a set
of experiments to characterized the in vitro responses of the
cochlear sensory epithelium to chemical Notch inhibition.
The activities of two novel GSIs were assessed in this study
and compared to the commercially available inhibitors. The
new compounds displayed intermediate potency to previously
reported GSIs in terms of IC50 for ATOH1 induction. Still they
induced comparable levels of hair cell generation ex vivo in all the
tested models. De novo hair cell induction appeared to be driven
by the transdifferentiation of supporting cells. Using ex vivo
culture and pharmacokinetic studies, it was possible to evaluate
their permeability through the round window membrane, assess
different formulations, and determine the local concentration
of these compounds into the inner ear. Ultimately, CPD3 was
further selected as the new chemical entity for a phase1/2 clinical
trial for mild-moderate SNHL (REGAIN trial1).
Gamma secretases have additional cellular targets other than
Notch receptors, including the amyloid precursor protein (APP),
for which they were initially designed, ERBB4, E-cadherin
and others (Andersson and Lendahl, 2014). Specifically for
the inner ear, the GSI effects observed in early postnatal
stages are comparable to genetic Notch suppression (Ni et al.,
2016a,b). In a direct comparison between GSI treatment (DAPT)
and Notch blocking antibody ex vivo, similar levels of hair
cell gene expression and de novo hair cell induction were
reported (Maass et al., 2015). GSIs such as LY411575 have
greater potency than the older transition state analogs and
DAPT-type peptidomimetics (Han and Shen, 2012). However,
the increased potency comes with some off-target effects,
such as non-selectivity toward proteases and can result
in inhibition of signal peptidases (Weihofen et al., 2003)
or the proteasome (Han and Shen, 2012). The choice of
the novel molecules assessed in this study was primarily
based on the ability to inhibit Notch signaling and reduce
potential off target effects. The intermediate potency of CPD3
and CPD8 and their concentration in perilymph, notably
higher than the IC50 for ATOH1 induction, were therefore
positively evaluated. Finally, local delivery to the inner ear
has the advantage to likely minimize systemic side effects
(Andersson and Lendahl, 2014).
The initial pharmacology of the different GSIs was
characterized in a human cell line that responds to Notch
inhibition and allows for quantitative comparisons of IC50 for
the upregulation of ATOH1. The phenotypic assays that followed
were performed in inner ear tissues intended to increasingly
represent targets of therapeutic treatment. In each of the assays,
the concentration ranges used were based on the concentrations
1https://www.regainyourhearing.eu/
achieved in pharmacokinetic tests (Figure 1). Using organotypic
cultures, CPD3 upregulated the expression of hair cell genes in
the tissue and resulted in an increased number of hair cells, in
particular OHCs in the apical region of the sensory epithelium, in
agreement with previously reported GSI studies (Korrapati et al.,
2013; Li et al., 2015; Maass et al., 2015; Ni et al., 2016b). CPD3
increased hair cells in undamaged cultures and also after ototoxic
damage induced by sisomicin. In the case of S. pneumoniae
exposure, we observed higher numbers of putative novel hair
cells, co-expressing Pou4f3 and Sox2 in the apical domain.
However, hair cell counts were increased in all cochlear regions
after GSI treatment. It remains unclear which mechanism may
contribute to this increase and whether GSIs may exert some
partial otoprotective function in this model.
While the reason for the higher regenerative potential of
the apical domain of the cochlear sensory epithelium in early
postnatal ears is likely related to the younger age of these cells
relative to the hair cells at the base (Driver and Kelley, 2020),
these differences in plasticity are unlikely to hold for the adult.
This regional effect may pose a problem for hair cell regeneration
as OHCs in the base are most vulnerable to damage (Liberman,
1990; Sha et al., 2001; Perny et al., 2016; Perny et al., 2017)
resulting in predominant high-frequency hearing loss.
The in vitro findings with rat explant cultures supported a
model where hair cells are generated by transdifferentiation of
supporting cells as immature hair cells expressing both Pou4f3
and Sox2, lacking hair bundles were identified, but these cells
did not incorporate EdU (Figure 3). This is in contrast with
mitogenic responses observed with murine tissue by us (Roccio
et al., unpublished data) and others (Li et al., 2015; Ni et al.,
2016b). Further, different supporting cell types responded to GSI
treatment and damage. In explants exposed to sisomicin, newly-
formed hair cells were detected adjacent to the 3rd row of hair
cells and therefore likely originated from transdifferentiation of
the 3rd Deiters’ cells/Hensen’s cells. In explants exposed to live
S. pneumoniae, newly-formed hair cells were located at different
locations across the medial-lateral axis of the sensory epithelium.
It is therefore plausible that different ototoxic damage models
may activate different supporting cell types, modifying their
response to regenerative molecules. Interestingly, ectopic hair
cells were not observed in the greater epithelial ridge, nor in the
inner hair cell region after GSI exposure.
Transdifferentiation of supporting cells to hair cells without
replenishment of the supporting cell pool may alter the epithelial
organization and therefore per se, impact the organ functionality.
Different studies have focused on simultaneous induction of
proliferation and differentiation of supporting cells to mimic
a regenerative response (Ni et al., 2016a,b; Shu et al., 2019).
Restoration of the original cellular organization remains a major
challenge to be solved in order to enable proper restoration
of organ function.
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FIGURE 6 | Ototoxic assay in cochlear organoid. (A) Immunostaining of untreated organoids for Myo7a and F-Actin at day 24. (B) Immunostaining of organoids for
Myo7a and F-Actin at day 24 after exposure for 2 h to sisomicin (500 µM) on day 20. Cells presenting signs of apoptosis are labeled with arrows. (C) Propidium
Iodide incorporation at day 24 is seen in a subset of hair cells after exposure to sisomicin. Scale bar: 25 µm. (D) Quantitative analysis of hair cells survival 1 week
after sisomicin exposure [HC number relative to the organoid volume in mm3 (×10−5)]. Control: n = 40; sisomicin: n = 12; sisomicin + CPD3; n = 9 (#p = 0.052;
∗∗∗p < 0.001; unpaired t-test with Welch’s correction). (E) Quantification of Sox2 positive cells after sisomicin damage and CPD3 exposure (n = 7). (F) CPD3 effects
on the percentage of Myo7a positive cells co-expressing Sox2 (∗∗p < 0.001, unpaired t-test with Welch’s correction; n = 8–9).
Organotypic cultures of the postnatal organ of Corti are well-
established and widely used tools to evaluate in vitro responses to
drugs as they can be directly exposed to selected concentrations
of compounds under controlled conditions. They also enable
the assessment of the anatomical location and the type of cells
that are affected by the treatment. However, any approach for
in vivo delivery will likely not match the high and precise
doses that can be tested in vitro. In order to complement
the pharmacological data, a different ex vivo model of the
whole cochlea from mice was established. The model aimed
to demonstrate that CPD3 could induce an increase in hair
cell number by local delivery and to corroborate the preclinical
pharmacokinetic tests documenting drug absorption into the
perilymph. CPD3 was tested in two vehicle formulations: 70%
PEG (Mizutari et al., 2013) and 10% POX (Gausterer et al.,
2020), designed to increase the residence time in vivo. In both
cases, the highest concentration of the compound led to a basal-
to-apical gradient of increased hair cell number. A decrease of
Sox2+ cells reaffirmed that GSI entered the cochlea and induced
hair cell formation, predominantly through transdifferentiation.
The data reported here are obtained from P1–2 mice. While
the model provides an initial, complementary approach to test
drug permeability and efficacy, it remains highly challenging to
establish similar ex vivo culture systems from older animals.
Finally, cochlear organoid models (McLean et al., 2017)
were successfully employed to compare the effectiveness of GSI
in a range of experiments testing hair cell regeneration. The
culture methods rely on a primary phase of cochlear progenitor
expansion followed by differentiation to hair cells by concomitant
Wnt activation and Notch inhibition (McLean et al., 2017;
Roccio et al., 2018; Lenz et al., 2019). This enabled a side-by-
side comparison of GSIs. In this case, the efficacy of hair cell
induction of CPD3 was comparable to LY411575, both in terms
of upregulation of hair cell genes, as well as the number of derived
hair cells at the end of the differentiation period. Comparable
findings were obtained from mouse and rat cultures. While a
direct comparison was not conducted, rat cochlear organoids
seemed to have a higher proportion of Sox2+ cells at the end of
differentiation. Hence, this provided a convenient model to test
supporting cell-dependent hair cell regeneration. The sensitivity
to sisomicin in rat organoids suggested a functional cochlear hair
cell phenotype. Interestingly, hair cells lost from the ototoxic
insult were replenished after CPD3 treatment (Figure 6).
Organoid culture models have the drawback that they lack
information concerning the precise cell type and anatomical
location where damage and regeneration occur, as supporting
cells derived from the entire cochlear duct are isolated,
pooled and cultured in homogeneous conditions. Furthermore,
the media composition has been selected to maximize the
proliferative and stem-like features of these cells, and findings
obtained in vitro may not be representative of in vivo responses
obtained in intact organs with single drugs. It is, however,
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possible to maintain these cultures for a prolonged time. Here,
we tested up to 1 month (20 days of differentiation 7 days after
damage). Optimization of the conditions may enable further
maturation to late postnatal stages. In contrast, ex vivo cultures
of the OC tend to lose tissue organization once cultured for
a prolonged time, and late postnatal tissue cannot be directly
isolated undamaged from the ossified inner ear. Benchmarking
in vitro derived hair cells and supporting cells from the organoid
cultures against primary tissue from late postnatal and adult
organs will be pivotal to better understand the advantages and
limitations of this model (Burns et al., 2015; Ranum et al., 2019;
Yu et al., 2019; Hoa et al., 2020).
Furthermore, validation of these strategies on human tissue
may further provide robust evidence for their clinical translation.
While human fetal and adult (postmortem or surgically derived
material) can be used for important validation studies, their
limited accessibility in fact strongly hampers the use in routine
or high throughput experimental settings (Chen et al., 2007;
Roccio et al., 2018; Taylor et al., 2018). Generation of human cell
types using stem cell technologies may provide alternative and
scalable tools for in vitro testing of drug therapies (Koehler et al.,
2017; Roccio, 2020). In conclusion, while the tested GSI reliably
enhanced de novo hair cell formation in vitro in all the presented
assays, a major future hurdle will be to generate advanced models
that are representative of mature or aged tissues to study disease
and regeneration in these settings prior to the translation to more
complex in vivo models.
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